Pharmaceutical Industry
CommentaryI’m an obesity medicine doctor and I’ve been on weight-loss drugs like Ozempic for a decade. Here’s why I think they aren’t a fad
By Angela FitchJuly 30, 2024
FinanceSwiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss
By Prarthana PrakashJuly 29, 2024
FinanceA CEO abruptly resigned from a board after leaked emails reportedly showed inappropriate influence
By Marion Halftermeyer and BloombergJuly 26, 2024
HealthSergey Brin is using money from selling his Tesla shares to bankroll a startup developing hallucinogenic mental-health treatments
By Marco Quiroz-GutierrezJuly 23, 2024
RetailAn obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche’s market value
By Naomi Kresge, Lisa Pham and BloombergJuly 23, 2024
HealthPharma giant Pfizer is trying to cash in on the weight loss drug craze with a new pill that could be a welcome needle-free alternative to pesky GLP-1 shots
By Damian Garde and BloombergJuly 11, 2024
CommentaryWhy investing in places like Birmingham, Alabama is key to securing U.S. biotech dominance as China tries to close the gap
By Katie Britt, Terri Sewell, Kay Ivey and Randall WoodfinJuly 3, 2024
CommentaryAlzheimer’s made my mom unable to recognize her grandkids. Breakthroughs too late for her can change the disease’s trajectory—if diagnosis and treatment start early
By Anne E. WhiteJuly 2, 2024
HealthFake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs
By Amanda LoudinJune 27, 2024
TechMeta axed his AI biology research team. Now this ‘Meta AI mafia’ member’s new startup has $142 million to chase his protein-generating dream
By Sharon GoldmanJune 25, 2024
Commentary‘A head-in-the-sand approach’: The U.S. strategic drug stockpile is inadequate for a bird flu outbreak
By Carolyn BarberJune 24, 2024
LeadershipForget expensive coaches, Paul Hudson, CEO of Sanofi turns to his three children for advice: ‘Through their eyes I get a glimpse into what the future looks like for the next generation’
By Peter VanhamJune 20, 2024
RetailOzempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled in front of Bernie Sanders to explain why
By Ryan HoggJune 17, 2024
Most Popular
